Ciphergen s Stock Regains 7 Percent of Value Lost After Positive Biomarker Discovery News | GenomeWeb

NEW YORK, May 26 (GenomeWeb News) - Shares in Ciphergen this afternoon regained the roughly 7 percent they lost yesterday despite news that the company discovered biomarkers that may predict the recurrence of prostate cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.